Trial Outcomes & Findings for Bringing Care to Patients: Patient-Centered Medical Home for Kidney Disease (NCT NCT02270515)

NCT ID: NCT02270515

Last Updated: 2017-04-07

Results Overview

Quality of life (QOL) was measured using the Kidney Disease Quality of Life-36 (KDQOL-36) survey, a kidney-disease-specific quality of life instrument that assesses five domains: general physical health, mental health, disease burden, disease symptoms, and disease effects. For all KDQOL scales, a higher score indicates better quality of life. All domain scales can range from 0-100.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

175 participants

Primary outcome timeframe

Baseline (0) to 18 months

Results posted on

2017-04-07

Participant Flow

The PCMH-KD model was implemented at two dialysis centers, an academic dialysis center and a private dialysis center. Patients were recruited, screened and enrolled at both sites. After consenting, study participants completed a baseline survey and on a rolling basis three follow-up interviews at six, twelve, and eighteen months.

Clinical data (six months prior to enrollment date) was collected from the electronic medical record for all participants to compare the "usual care" for enrolled patients with the care received during the PCMH-KD intervention.

Participant milestones

Participant milestones
Measure
PCMH-KD Dialysis Care
Dialysis care team is expanded to include a primary care doctor, nurse coordinator, community health worker, and a pharmacist. Patient-Centered Medical Home for Kidney Disease (PCMH-KD): A PCMH-KD enhances the usual dialysis care team by adding a primary care doctor, pharmacist, nurse coordinator and community health worker to the care team.
Intervention Period 1: 0-6 Months
STARTED
175
Intervention Period 1: 0-6 Months
COMPLETED
159
Intervention Period 1: 0-6 Months
NOT COMPLETED
16
Intervention Period 2: 6-12 Months
STARTED
159
Intervention Period 2: 6-12 Months
COMPLETED
127
Intervention Period 2: 6-12 Months
NOT COMPLETED
32
Intervention Period 3: 12-18 Months
STARTED
127
Intervention Period 3: 12-18 Months
COMPLETED
103
Intervention Period 3: 12-18 Months
NOT COMPLETED
24

Reasons for withdrawal

Reasons for withdrawal
Measure
PCMH-KD Dialysis Care
Dialysis care team is expanded to include a primary care doctor, nurse coordinator, community health worker, and a pharmacist. Patient-Centered Medical Home for Kidney Disease (PCMH-KD): A PCMH-KD enhances the usual dialysis care team by adding a primary care doctor, pharmacist, nurse coordinator and community health worker to the care team.
Intervention Period 1: 0-6 Months
Withdrawal by Subject
1
Intervention Period 1: 0-6 Months
No longer patient at study site
5
Intervention Period 1: 0-6 Months
Received transplant
3
Intervention Period 1: 0-6 Months
Death
7
Intervention Period 2: 6-12 Months
Withdrawal by Subject
2
Intervention Period 2: 6-12 Months
No longer patient at study site
7
Intervention Period 2: 6-12 Months
Received transplant
1
Intervention Period 2: 6-12 Months
Death
5
Intervention Period 2: 6-12 Months
Intervention ended before follow-up
17
Intervention Period 3: 12-18 Months
Withdrawal by Subject
1
Intervention Period 3: 12-18 Months
No longer patient at study site
2
Intervention Period 3: 12-18 Months
Received transplant
2
Intervention Period 3: 12-18 Months
Death
3
Intervention Period 3: 12-18 Months
Intervention ended before follow-up
16

Baseline Characteristics

No Response: 1 participant

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
PCMH-KD Dialysis Care
n=175 Participants
Enrolled patients had access to an expanded care team inlcuding a primary care doctor, nurse coordinator, community health worker, and pharmacist.
Age, Continuous
54.4 years
STANDARD_DEVIATION 15 • n=175 Participants
Sex: Female, Male
Female
78 Participants
n=175 Participants
Sex: Female, Male
Male
97 Participants
n=175 Participants
Race/Ethnicity, Customized
Race/Ethnicity · African-American
86 Participants
n=175 Participants
Race/Ethnicity, Customized
Race/Ethnicity · Hispanic/other
89 Participants
n=175 Participants
Region of Enrollment
United States
175 participants
n=175 Participants
Interview language
English
117 Participants
n=175 Participants
Interview language
Spanish
58 Participants
n=175 Participants
Race/ethnicity*language
African-American
86 Participants
n=175 Participants
Race/ethnicity*language
Hispanic/other, English interview
31 Participants
n=175 Participants
Race/ethnicity*language
Hispanic, Spanish interview
58 Participants
n=175 Participants
Primary language
English
107 Participants
n=175 Participants
Primary language
Spanish/other
54 Participants
n=175 Participants
Primary language
Both equally
14 Participants
n=175 Participants
Marital status
Single, never married
70 Participants
n=175 Participants
Marital status
Married/Living with a partner
62 Participants
n=175 Participants
Marital status
Widowed
22 Participants
n=175 Participants
Marital status
Separated, divorced
21 Participants
n=175 Participants
Children under 18 yr in household
No children under 18 yr in household
132 Participants
n=175 Participants
Children under 18 yr in household
1 child under 18 yr in household
22 Participants
n=175 Participants
Children under 18 yr in household
≥ 2 children under 18 yr in household
21 Participants
n=175 Participants
Education
Not HS graduate
62 Participants
n=175 Participants
Education
HS graduate/GED
100 Participants
n=175 Participants
Education
Bachelor's degree
13 Participants
n=175 Participants
Employment
Full-time/Self-employed
16 Participants
n=174 Participants • No Response: 1 participant
Employment
Part-time
15 Participants
n=174 Participants • No Response: 1 participant
Employment
Not employed
143 Participants
n=174 Participants • No Response: 1 participant
Income
Less than $20,000
108 Participants
n=175 Participants
Income
$20,000-$39,999
30 Participants
n=175 Participants
Income
≥ $40,000
22 Participants
n=175 Participants
Income
Refused
15 Participants
n=175 Participants
Dialysis History
Years on dialysis
4.4 years
STANDARD_DEVIATION 5.2 • n=174 Participants • Missing dialysis information for one (1) study participant.
Dialysis History
Years at current center
3.3 years
STANDARD_DEVIATION 4.4 • n=174 Participants • Missing dialysis information for one (1) study participant.
Primary transportation to clinic
Car (drive or ride)
87 Participants
n=175 Participants
Primary transportation to clinic
Transit (L train or bus)
14 Participants
n=175 Participants
Primary transportation to clinic
Medicar (Medicaid)
42 Participants
n=175 Participants
Primary transportation to clinic
PACE paratransit/door to door
17 Participants
n=175 Participants
Primary transportation to clinic
Other
15 Participants
n=175 Participants
Insurance (any type)
Yes
158 Participants
n=175 Participants
Insurance (any type)
No
17 Participants
n=175 Participants
Comorbidities
None
15 Participants
n=175 Participants
Comorbidities
1
55 Participants
n=175 Participants
Comorbidities
2 to 3
91 Participants
n=175 Participants
Comorbidities
4 to 7
14 Participants
n=175 Participants
Stressful life events (e.g. hospitalization, loss of employment or family member) in past 6 months
Yes
79 Participants
n=175 Participants
Stressful life events (e.g. hospitalization, loss of employment or family member) in past 6 months
No
96 Participants
n=175 Participants
Regular doctor (Primary Care Physician)
Has regular personal doctor
104 Participants
n=175 Participants
Regular doctor (Primary Care Physician)
No regular personal doctor
71 Participants
n=175 Participants
Primary Care Assessment Survey (PCAS)
Longitudinal Continuity
52.9 units on a scale
STANDARD_DEVIATION 37.2 • n=104 Participants • 1. Longitudinal Continuity, Comprehensive Knowledge, Communication and Interpersonal Treatment scores are calculated for patients who reported having a regular personal doctor. 2. Integration of Care is calculated for patients who reported having a regular personal doctor and reported receiving referrals. 3. Numbers differ due to missing data.
Primary Care Assessment Survey (PCAS)
Comprehensive Knowledge
65.4 units on a scale
STANDARD_DEVIATION 21.3 • n=104 Participants • 1. Longitudinal Continuity, Comprehensive Knowledge, Communication and Interpersonal Treatment scores are calculated for patients who reported having a regular personal doctor. 2. Integration of Care is calculated for patients who reported having a regular personal doctor and reported receiving referrals. 3. Numbers differ due to missing data.
Primary Care Assessment Survey (PCAS)
Communication
74.3 units on a scale
STANDARD_DEVIATION 18.8 • n=104 Participants • 1. Longitudinal Continuity, Comprehensive Knowledge, Communication and Interpersonal Treatment scores are calculated for patients who reported having a regular personal doctor. 2. Integration of Care is calculated for patients who reported having a regular personal doctor and reported receiving referrals. 3. Numbers differ due to missing data.
Primary Care Assessment Survey (PCAS)
Interpersonal Treatment
75.2 units on a scale
STANDARD_DEVIATION 17.3 • n=104 Participants • 1. Longitudinal Continuity, Comprehensive Knowledge, Communication and Interpersonal Treatment scores are calculated for patients who reported having a regular personal doctor. 2. Integration of Care is calculated for patients who reported having a regular personal doctor and reported receiving referrals. 3. Numbers differ due to missing data.
Primary Care Assessment Survey (PCAS)
Integration of Care
67.8 units on a scale
STANDARD_DEVIATION 22.2 • n=64 Participants • 1. Longitudinal Continuity, Comprehensive Knowledge, Communication and Interpersonal Treatment scores are calculated for patients who reported having a regular personal doctor. 2. Integration of Care is calculated for patients who reported having a regular personal doctor and reported receiving referrals. 3. Numbers differ due to missing data.
Self-Efficacy for Managing Chronic Disease (SEMCD)
7.2 units on scale
STANDARD_DEVIATION 2.0 • n=174 Participants • Missing data for (1) study participant.
Chronic Hemodialysis Knowledge Survey (CHeKS)
51.8 units on scale
STANDARD_DEVIATION 15.7 • n=174 Participants • Missing data for one (1) study participant.
Health Literacy
Adequate (3-8)
106 Participants
n=175 Participants
Health Literacy
Inadequate/marginal (9-15)
69 Participants
n=175 Participants

PRIMARY outcome

Timeframe: Baseline (0) to 18 months

Population: Overall number of participants analyzed are the number who completed the KDQOL at each visit. They differ slightly from the number of participants in the flow chart due to missing KDQOL data. Ns are slightly lower for some scale scores due to missing items (see below).

Quality of life (QOL) was measured using the Kidney Disease Quality of Life-36 (KDQOL-36) survey, a kidney-disease-specific quality of life instrument that assesses five domains: general physical health, mental health, disease burden, disease symptoms, and disease effects. For all KDQOL scales, a higher score indicates better quality of life. All domain scales can range from 0-100.

Outcome measures

Outcome measures
Measure
Baseline
n=174 Participants
KDQOL collected at Baseline
6 Months
n=153 Participants
KDQOL collected at 6 months
12 Months
n=125 Participants
KDQOL collected at 12 months
18 Months
n=103 Participants
KDQOL collected at 18 months
Kidney Disease Quality of Life (KDQOL-36) Mean Scale Scores at Baseline, 6, 12 and 18 Months: Unadjusted
Physical Component Summary (PCS)
35.5 units on a scale
Standard Deviation 10.2
38.4 units on a scale
Standard Deviation 11.4
36.3 units on a scale
Standard Deviation 11.2
36.8 units on a scale
Standard Deviation 11.2
Kidney Disease Quality of Life (KDQOL-36) Mean Scale Scores at Baseline, 6, 12 and 18 Months: Unadjusted
Mental Component Summary (MCS)
49.2 units on a scale
Standard Deviation 10.6
50.4 units on a scale
Standard Deviation 11.3
51.8 units on a scale
Standard Deviation 10.2
52.4 units on a scale
Standard Deviation 9.7
Kidney Disease Quality of Life (KDQOL-36) Mean Scale Scores at Baseline, 6, 12 and 18 Months: Unadjusted
Burden of Kidney Disease
46.5 units on a scale
Standard Deviation 27.1
48.8 units on a scale
Standard Deviation 26.7
49.6 units on a scale
Standard Deviation 23.3
51.2 units on a scale
Standard Deviation 30.3
Kidney Disease Quality of Life (KDQOL-36) Mean Scale Scores at Baseline, 6, 12 and 18 Months: Unadjusted
Symptoms/Problems of Kidney Disease
76.5 units on a scale
Standard Deviation 15.9
79.9 units on a scale
Standard Deviation 14.2
79.7 units on a scale
Standard Deviation 13.6
76.8 units on a scale
Standard Deviation 16.7
Kidney Disease Quality of Life (KDQOL-36) Mean Scale Scores at Baseline, 6, 12 and 18 Months: Unadjusted
Effects of Kidney Disease
72.3 units on a scale
Standard Deviation 20.6
76.3 units on a scale
Standard Deviation 20.6
78.3 units on a scale
Standard Deviation 18.9
76.1 units on a scale
Standard Deviation 20.1

PRIMARY outcome

Timeframe: Baseline (0) to 18 months

Population: Ns shown in the table are the number of records at each visit with data for the KDQOL scale score and all covariates. All available records were used to estimate the adjusted means. For all scales, N=173 participants; 2 were excluded due to missing data for covariates: dialysis vintage and PCP at baseline.

Quality of life (QOL) was measured using the Kidney Disease Quality of Life-36 (KDQOL-36) survey, a kidney-disease-specific quality of life instrument that assesses five domains: general physical health, mental health, disease burden, disease symptoms, and disease effects. For all KDQOL scales, a higher score indicates better quality of life. All domain scales can range from 0-100. Adjusted means are from random-intercept linear mixed models with an AR(1) covariance pattern in the residual, adjusted for baseline age, sex, race (AA, all other), interview language, dialysis vintage (months), site, education (not HS grad, HS grad), marital status (married or living with partner, other), self-reported diabetes at baseline, PCP at baseline, urea reduction ratio (URR), hemoglobin (g/dL), and albumin (g/dL). The 3 lab values are time-varying covariates.

Outcome measures

Outcome measures
Measure
Baseline
n=172 Participants
KDQOL collected at Baseline
6 Months
n=147 Participants
KDQOL collected at 6 months
12 Months
n=125 Participants
KDQOL collected at 12 months
18 Months
n=102 Participants
KDQOL collected at 18 months
Kidney Disease Quality of Life (KDQOL-36) Mean Scale Scores at Baseline, 6, 12 and 18 Months: Adjusted
Physical Component Summary (PCS)
35.7 units on a scale
Standard Error 0.9
38.3 units on a scale
Standard Error 1.0
36.0 units on a scale
Standard Error 1.0
36.7 units on a scale
Standard Error 1.1
Kidney Disease Quality of Life (KDQOL-36) Mean Scale Scores at Baseline, 6, 12 and 18 Months: Adjusted
Mental Component Summary (MCS)
48.9 units on a scale
Standard Error 0.9
50.1 units on a scale
Standard Error 1.0
51.4 units on a scale
Standard Error 1.0
51.7 units on a scale
Standard Error 1.1
Kidney Disease Quality of Life (KDQOL-36) Mean Scale Scores at Baseline, 6, 12 and 18 Months: Adjusted
Burden of Kidney Disease
45.8 units on a scale
Standard Error 2.4
48.4 units on a scale
Standard Error 2.5
49.0 units on a scale
Standard Error 2.5
49.7 units on a scale
Standard Error 2.7
Kidney Disease Quality of Life (KDQOL-36) Mean Scale Scores at Baseline, 6, 12 and 18 Months: Adjusted
Symptoms/Problems of Kidney Disease
77.1 units on a scale
Standard Error 1.3
79.6 units on a scale
Standard Error 1.4
79.3 units on a scale
Standard Error 1.5
76.4 units on a scale
Standard Error 1.5
Kidney Disease Quality of Life (KDQOL-36) Mean Scale Scores at Baseline, 6, 12 and 18 Months: Adjusted
Effects of Kidney Disease
73.0 units on a scale
Standard Error 1.8
77.2 units on a scale
Standard Error 1.9
79.6 units on a scale
Standard Error 2.0
76.9 units on a scale
Standard Error 2.1

PRIMARY outcome

Timeframe: Baseline (0) to 18 months

Population: All records with data for the KDQOL scale score (dependent variable) and covariates were included in the analysis. Two participants were excluded due to missing data for covariates: dialysis vintage and PCP at baseline. The previous table (adjusted means) shows the number of records with complete data for each visit.

Quality of life (QOL) was measured using the Kidney Disease Quality of Life-36 (KDQOL-36) survey, a kidney-disease-specific quality of life instrument that assesses five domains: general physical health, mental health, disease burden, disease symptoms, and disease effects. For all KDQOL scales, a higher score indicates better quality of life. All domain scales can range from 0-100.

Outcome measures

Outcome measures
Measure
Baseline
n=173 Participants
KDQOL collected at Baseline
6 Months
n=173 Participants
KDQOL collected at 6 months
12 Months
n=173 Participants
KDQOL collected at 12 months
18 Months
n=173 Participants
KDQOL collected at 18 months
Estimated KDQOL-36 Scale Score Change for Each 6-month Period and 0-18 Months: Adjusted Random-intercept Models
Physical Component Summary (PCS)
2.6 units on a scale
Standard Error 0.8
-2.3 units on a scale
Standard Error 0.9
0.7 units on a scale
Standard Error 1.0
1.0 units on a scale
Standard Error 1.0
Estimated KDQOL-36 Scale Score Change for Each 6-month Period and 0-18 Months: Adjusted Random-intercept Models
Mental Component Summary (MCS)
1.2 units on a scale
Standard Error 1.0
1.3 units on a scale
Standard Error 1.0
0.3 units on a scale
Standard Error 1.1
2.8 units on a scale
Standard Error 1.1
Estimated KDQOL-36 Scale Score Change for Each 6-month Period and 0-18 Months: Adjusted Random-intercept Models
Burden of Kidney Disease
2.6 units on a scale
Standard Error 2.0
0.6 units on a scale
Standard Error 2.0
0.6 units on a scale
Standard Error 2.2
3.8 units on a scale
Standard Error 2.1
Estimated KDQOL-36 Scale Score Change for Each 6-month Period and 0-18 Months: Adjusted Random-intercept Models
Symptoms/Problems of Kidney Disease
2.6 units on a scale
Standard Error 1.1
-0.4 units on a scale
Standard Error 1.2
-2.9 units on a scale
Standard Error 1.3
-0.7 units on a scale
Standard Error 1.3
Estimated KDQOL-36 Scale Score Change for Each 6-month Period and 0-18 Months: Adjusted Random-intercept Models
Effects of Kidney Disease
4.3 units on a scale
Standard Error 1.5
2.4 units on a scale
Standard Error 1.6
-2.8 units on a scale
Standard Error 1.8
3.9 units on a scale
Standard Error 1.7

Adverse Events

PCMH-KD Dialysis Care

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Dr. Denise M. Hynes, Professor, College of Medicine

University of Illinois, Chicago

Phone: 312-355-0083

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place